CONMED Valuation
| CNMD Stock | USD 67.69 0.83 1.24% |
At this time, the firm appears to be undervalued. CONMED shows a prevailing Real Value of $74.91 per share. The current price of the firm is $67.69. Our model approximates the value of CONMED from reviewing the firm fundamentals such as profit margin of 0.10 %, and Return On Equity of 0.15 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CONMED's valuation include:
Undervalued
Today
Please note that CONMED's price fluctuation is very steady at this time. Calculation of the real value of CONMED is based on 3 months time horizon. Increasing CONMED's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CONMED stock is determined by what a typical buyer is willing to pay for full or partial control of CONMED. Since CONMED is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CONMED Stock. However, CONMED's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 67.69 | Real 74.91 | Target 81.14 | Hype 67.71 |
The real value of CONMED Stock, also known as its intrinsic value, is the underlying worth of CONMED Company, which is reflected in its stock price. It is based on CONMED's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CONMED's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CONMED helps investors to forecast how CONMED stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CONMED more accurately as focusing exclusively on CONMED's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CONMED's intrinsic value based on its ongoing forecasts of CONMED's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CONMED's closest peers. If more than one evaluation category is relevant for CONMED we suggest using both methods to arrive at a better estimate.
CONMED Cash |
|
CONMED Valuation Trend
Comparing CONMED's enterprise value against its market capitalization is a good way to estimate the value of CONMED uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
CONMED Revenue by Product
CONMED Total Value Analysis
CONMED is currently expected to have valuation of 2.97 B with market capitalization of 2.09 B, debt of 991.25 M, and cash on hands of 33.35 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CONMED fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.97 B | 2.09 B | 991.25 M | 33.35 M |
CONMED Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The book value of CONMED was currently reported as 30.21. The company has Price/Earnings (P/E) ratio of 188.03. CONMED last dividend was issued on the 20th of December 2024. The entity had 3:2 split on the 10th of September 2001. Based on the measurements of operating efficiency obtained from CONMED's historical financial statements, CONMED is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 151.4 M | 144.2 M |
|
|
CONMED Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CONMED has an asset utilization ratio of 54.12 percent. This indicates that the Company is making $0.54 for each dollar of assets. An increasing asset utilization means that CONMED is more efficient with each dollar of assets it utilizes for everyday operations.CONMED Ownership Allocation
The majority of CONMED outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CONMED to benefit from reduced commissions. Thus, institutional investors are subject to a different set of regulations than regular investors in CONMED. Please pay attention to any change in the institutional holdings of CONMED as this could imply that something significant has changed or is about to change at the company.CONMED Profitability Analysis
The company reported the previous year's revenue of 1.24 B. Net Income was 64.46 M with profit before overhead, payroll, taxes, and interest of 718.96 M.CONMED Past Distributions to stockholders
| 4th of October 2024 | ||
| 5th of July 2024 | ||
| 5th of April 2024 | ||
| 5th of January 2024 | ||
| 5th of October 2023 | ||
| 15th of September 2023 | ||
| 5th of July 2023 | ||
| 15th of June 2023 | ||
| 5th of April 2023 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CONMED's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CONMED and how it compares across the competition.
About CONMED Valuation
The stock valuation mechanism determines CONMED's current worth on a weekly basis. Our valuation model uses a comparative analysis of CONMED. We calculate exposure to CONMED's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CONMED's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 777.7 M | 816.6 M | |
| Pretax Profit Margin | 0.07 | 0.08 | |
| Operating Profit Margin | 0.12 | 0.11 | |
| Net Profit Margin | 0.06 | 0.05 | |
| Gross Profit Margin | 0.49 | 0.42 |
CONMED Quarterly Retained Earnings |
|
A single share of CONMED represents a small ownership stake in the entity. As a stockholder of CONMED, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
CONMED Dividends Analysis For Valuation
At present, CONMED's Dividend Payout Ratio is projected to increase slightly based on the last few years of reporting. . The current year's Retained Earnings is expected to grow to about 546.4 M, whereas Retained Earnings Total Equity is forecasted to decline to about 467.3 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 22.1 M | 18.7 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.44 | 0.76 | |
| Dividend Paid And Capex Coverage Ratio | 3.31 | 2.85 |
There are various types of dividends CONMED can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of CONMED shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from CONMED directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When CONMED pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of CONMED by the value of the dividends paid out.
CONMED Growth Indicators
Investing in growth stocks can be very risky. If the company such as CONMED does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 31.5 M | |
| Quarterly Earnings Growth Y O Y | 2.14 | |
| Forward Price Earnings | 27.027 |
CONMED Current Valuation Indicators
Valuation refers to the process of determining the present value of CONMED and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value CONMED we look at many different elements of the entity such as CONMED's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CONMED, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CONMED's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CONMED's worth.Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |